# Protalix BioTherapeutics, Inc.: Form 8-K, filed May 5, 2023

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2023-05-05
- Accepted by EDGAR: May 5, 2023, 06:56 ET
- Period: 2023-05-05
- Accession: 0001558370-23-008188
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837023008188/plx-20230505x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837023008188/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837023008188/plx-20230505x8k.htm

Filed May 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-008188. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
